Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Study in the Effect of EZH2 Gene Targeting siRNA on Cell Death in HL-60 Cell Line

View through CrossRef
Abstract Objective: To study small interfering RNA (siRNA) targeting EZH2 gene effect on cell proliferation, apoptosis and histone modulation in HL-60 cells line. Methods: (1) Three siRNA segments targeting EZH2 gene were designed and transfected into HL-60 cells by LipofectamineTM 2000. The optimal segment was screened by RT-PCR. (2) Cell growth inhibited by EZH2 siRNA was determined by WST-1. Cell apoptosis was measured by Flow cytometry. (3) The expression of procaspase-3, procaspase-9, Bcl-2, and Bax was detected by Western blot. The levels of histone H3 lysine27 dimethylation and trimethylation and histone acetylatiom of H3 were evaluated by Western blot. Results: (1) The efficiency of transfection with EZH2 siRNA for 6 hours was (82 ±2.97)%. The sequence of optimal segment of EZH2 siRNA was sense 5'- GAGGGAAAGUGUAUGAUAATT -3',antisense 5'- UUAUCAUACACUUUC CCUCTT -3'。 (2) EZH2 siRNA suppressed the proliferation of HL-60 cells. (3) EZH2 siRNA downregulates the expression of procaspase-3, procaspase-9, Bcl-2 and upregulates the expression of Bax and induced cells apoptosis. (4) EZH2 siRNA suppressed the protein and mRNA of EZH2 in HL-60 cells. The levels of histone H3 lysine27 dimethylation and trimethylation was down regulated and histone acetylatiom of H3 was up regulated. Conclusions: (1) LipofectamineTM2000 transfected siRNA for EZH2 gene into HL-60 cells has high efficiency. (2) EZH2 siRNA inhibits cell growth and induces cell apoptosis in HL-60 cell line. It might be a new therapeutic target in human leukemia. (3) EZH2 siRNA downregulates the levels of histone H3 lysine27 dimethylation and trimethylation and upregulates histone acetylation of H3. The mechanism of EZH2 effect on histone acetylation need to be further studied. RNAi technology is expected to become a new tool for targeted gene therapy of acute leukemia, and EZH2 might be one of the targets of gene therapy for leukemia. Disclosures No relevant conflicts of interest to declare.
American Society of Hematology
Title: Study in the Effect of EZH2 Gene Targeting siRNA on Cell Death in HL-60 Cell Line
Description:
Abstract Objective: To study small interfering RNA (siRNA) targeting EZH2 gene effect on cell proliferation, apoptosis and histone modulation in HL-60 cells line.
Methods: (1) Three siRNA segments targeting EZH2 gene were designed and transfected into HL-60 cells by LipofectamineTM 2000.
The optimal segment was screened by RT-PCR.
(2) Cell growth inhibited by EZH2 siRNA was determined by WST-1.
Cell apoptosis was measured by Flow cytometry.
(3) The expression of procaspase-3, procaspase-9, Bcl-2, and Bax was detected by Western blot.
The levels of histone H3 lysine27 dimethylation and trimethylation and histone acetylatiom of H3 were evaluated by Western blot.
Results: (1) The efficiency of transfection with EZH2 siRNA for 6 hours was (82 ±2.
97)%.
The sequence of optimal segment of EZH2 siRNA was sense 5'- GAGGGAAAGUGUAUGAUAATT -3',antisense 5'- UUAUCAUACACUUUC CCUCTT -3'。 (2) EZH2 siRNA suppressed the proliferation of HL-60 cells.
(3) EZH2 siRNA downregulates the expression of procaspase-3, procaspase-9, Bcl-2 and upregulates the expression of Bax and induced cells apoptosis.
(4) EZH2 siRNA suppressed the protein and mRNA of EZH2 in HL-60 cells.
The levels of histone H3 lysine27 dimethylation and trimethylation was down regulated and histone acetylatiom of H3 was up regulated.
Conclusions: (1) LipofectamineTM2000 transfected siRNA for EZH2 gene into HL-60 cells has high efficiency.
(2) EZH2 siRNA inhibits cell growth and induces cell apoptosis in HL-60 cell line.
It might be a new therapeutic target in human leukemia.
(3) EZH2 siRNA downregulates the levels of histone H3 lysine27 dimethylation and trimethylation and upregulates histone acetylation of H3.
The mechanism of EZH2 effect on histone acetylation need to be further studied.
RNAi technology is expected to become a new tool for targeted gene therapy of acute leukemia, and EZH2 might be one of the targets of gene therapy for leukemia.
Disclosures No relevant conflicts of interest to declare.

Related Results

EZH2-miRNA Positive Feedback Promotes Tumor Growth in Ovarian Cancer
EZH2-miRNA Positive Feedback Promotes Tumor Growth in Ovarian Cancer
Enhancer of zester homolog 2 (EZH2), a histone methyl transferase that mediates H3K27me3 through polycomb repressive complex 2 (PRC2), is overexpressed in ovarian cancer and promot...
Data from Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer
Data from Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer
<div>AbstractPurpose:<p>Deregulation or mutation of the <i>EZH2</i> gene causes various tumors, including clear cell renal cell carcinoma (ccRCC). Although ...
Data from Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer
Data from Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer
<div>AbstractPurpose:<p>Deregulation or mutation of the <i>EZH2</i> gene causes various tumors, including clear cell renal cell carcinoma (ccRCC). Although ...
Abstract OI: Novel non-canonical functions of EZH2 in triple negative breast cancer
Abstract OI: Novel non-canonical functions of EZH2 in triple negative breast cancer
Abstract Patients with distant metastasis at the time of diagnosis have significantly worse prognosis. Triple negative breast carcinomas (TNBC) are heterogeneous tum...
Bidirectional Effects of EZH2 Inhibitor in Endometriosis
Bidirectional Effects of EZH2 Inhibitor in Endometriosis
Endometriosis is a complex disorder that afflicts many women with chronic pelvic pain and infertility. It is believed that polycomb group of proteins, such as enhancer of zeste hom...
MEDB-83. A novel epigenetic nanotherapeutic strategy to induce medulloblastoma differentiation
MEDB-83. A novel epigenetic nanotherapeutic strategy to induce medulloblastoma differentiation
Abstract The histone-lysine N-methyltransferase EZH2 is the catalytic component of the PRC2 complex and is overexpressed in several medulloblastoma subtypes. However...
EZH2 regulates the invasiveness of gastric cancer probably by activating the Wnt signaling pathway
EZH2 regulates the invasiveness of gastric cancer probably by activating the Wnt signaling pathway
Abstract Aims and background Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide, and poses major treatment challenges due ...
ERK5 knock down aggravates detrimental effects of hypothermal stimulation on cardiomyocytes via Bim upregulation
ERK5 knock down aggravates detrimental effects of hypothermal stimulation on cardiomyocytes via Bim upregulation
Objectives Our study was designed to investigate role of ERK5/Bim pathway in hypothermal stimulation-induced damage or apoptosis of cardiomyocytes. ...

Back to Top